Pathway enrichment analysis of the top 10 targets by degree value revealed that the relaxin signaling, protein digestion and absorption, and PI3K-Akt signaling pathways were closely associated with MASLD development (Fig. 4D). The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.